# The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic Arthritis

> **NCT06463379** · PHASE3 · RECRUITING · sponsor: **Sohag University** · enrollment: 215 (estimated)

## Conditions studied

- Refractory Juvenile Idiopathic Arthritis (Despite 2 DMARDs Still Active)

## Interventions

- **DRUG:** Solumedrol

## Key facts

- **NCT ID:** NCT06463379
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2024-08-31
- **Final completion:** 2024-08-31
- **Target enrollment:** 215 (ESTIMATED)
- **Last updated:** 2024-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06463379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06463379, "The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic Arthritis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06463379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*